Viewing Study NCT00000903


Ignite Creation Date: 2025-12-24 @ 7:16 PM
Ignite Modification Date: 2026-01-05 @ 5:15 PM
Study NCT ID: NCT00000903
Status: COMPLETED
Last Update Posted: 2012-05-21
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module